532 related articles for article (PubMed ID: 17343373)
1. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.
Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2007 Apr; 50(7):1651-7. PubMed ID: 17343373
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides.
Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
Bioorg Med Chem Lett; 2007 Feb; 17(4):987-92. PubMed ID: 17157501
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides.
Wilkinson BL; Innocenti A; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2008 Mar; 51(6):1945-53. PubMed ID: 18307288
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of carbonic anhydrase isozymes with benzene sulfonamides incorporating thio, sulfinyl and sulfonyl glycoside moieties.
Singer M; Lopez M; Bornaghi LF; Innocenti A; Vullo D; Supuran CT; Poulsen SA
Bioorg Med Chem Lett; 2009 Apr; 19(8):2273-6. PubMed ID: 19286378
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
[TBL] [Abstract][Full Text] [Related]
7. Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis.
Wang ZC; Qin YJ; Wang PF; Yang YA; Wen Q; Zhang X; Qiu HY; Duan YT; Wang YT; Sang YL; Zhu HL
Eur J Med Chem; 2013 Aug; 66():1-11. PubMed ID: 23777898
[TBL] [Abstract][Full Text] [Related]
8. A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing".
Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Supuran CT; Poulsen SA
J Med Chem; 2006 Nov; 49(22):6539-48. PubMed ID: 17064072
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
Innocenti A; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(22):5703-7. PubMed ID: 15482952
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
Winum JY; Thiry A; Cheikh KE; Dogné JM; Montero JL; Vullo D; Scozzafava A; Masereel B; Supuran CT
Bioorg Med Chem Lett; 2007 May; 17(10):2685-91. PubMed ID: 17376683
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
[TBL] [Abstract][Full Text] [Related]
13. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.
Agrawal VK; Bano S; Supuran CT; Khadikar PV
Eur J Med Chem; 2004 Jul; 39(7):593-600. PubMed ID: 15236839
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered.
Vullo D; Scozzafava A; Pastorekova S; Pastorek J; Supuran CT
Bioorg Med Chem Lett; 2004 May; 14(9):2351-6. PubMed ID: 15081039
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
18. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of carbonic anhydrase isozymes I, II and IX with benzenesulfonamides containing an organometallic moiety.
Salmon AJ; Williams ML; Innocenti A; Vullo D; Supuran CT; Poulsen SA
Bioorg Med Chem Lett; 2007 Sep; 17(18):5032-5. PubMed ID: 17681760
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties.
Sethi KK; Verma SM; Tanç M; Purper G; Calafato G; Carta F; Supuran CT
Bioorg Med Chem; 2014 Mar; 22(5):1586-95. PubMed ID: 24513184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
